In this common disease, which is highly contagious, the above, combined with the following will be found highly efficient: R Liquor Kali arsenit... Vini ferri...... M. Sig. Teaspoonful in water after meals. gtt. xxiv 3iii For Literature and Reports Address PHENIQUE CHEMICAL COMPANY. ST. LOUIS, MO., U. S. A. Inclose a Herald Coupon when you write. 41 BUT CONSECUTIVE DIABETES MELLITUS ARSEN AURO HAS SHOWN ITSELF TO BE A POSITIVE SPECIFIC: IT MUST BE USED PROPERLY. Administer in at least a half tumbler of water (three times daily, after meals), beginning with a small dose (say 6 drops), and increasing one drop each day. Best results are only obtained by pushing Arsenauro and Mercauro to point of toleration in each individual case (keeping the patient as near that point as possible). The maximum dose varies widely, some patients taking eighty-five drops three times daily, others being unable to reach a dose of over ten drops. When reaching point of toleration, (manifested by the usual signs, such as puffiness under the lids, loose, griping evacuations, frontal headache, dizziness, tingling of the fingers, etc.), medication should be stopped for twenty-four hours, then resumed with dose slightly less than the one administered when toleration point was reached. Patient should be maintained upon this ascertained limit for a protracted period. CHAS. ROOME PARMELE CO., 36 PLATT STREET, NEW YORK. In this common disease, which is highly contagious, the above, combined with the following will be found highly efficient: R Liquor Kali arsenit.. Vini ferri...... M. Sig. Teaspoonful in water after meals. gtt. xxiv 3iii CAUTION.-Beware of Substitutes Offered for Campho-Phénique. 41 BUT CONSECUTIVE DIABETES MELLITUS ARSEN AURO HAS SHOWN ITSELF TO BE A POSITIVE SPECIFIC IT MUST BE USED PROPERLY. Administer in at least a half tumbler of water (three times daily, after meals), beginning with a small dose (say 6 drops), and increasing one drop each day. Best results are only obtained by pushing Arsenauro and Mercauro to point of toleration in each individual case (keeping the patient as near that point as possible). The maximum dose varies widely, some patients taking eighty-five drops three times daily, others being unable to reach a dose of over ten drops. When reaching point of toleration, (manifested by the usual signs, such as puffiness under the lids, loose, griping evacuations, frontal headache, dizziness, tingling of the fingers, etc.), medication should be stopped for twenty-four hours, then resumed with dose slightly less than the one administered when toleration point was reached. Patient should be maintained upon this ascertained limit for a protracted period. CHAS. ROOME PARMELE CO., 36 PLATT STREET, NEW YORK. |